Consensus Middle East and North Africa Registry on Inborn Errors of Immunity

Affiliations


Abstract

Background: Inborn errors of immunity (IEIs) are a heterogeneous group of genetic defects of immunity, which cause high rates of morbidity and mortality mainly among children due to infectious and non-infectious complications. The IEI burden has been critically underestimated in countries from middle- and low-income regions and the majority of patients with IEI in these regions lack a molecular diagnosis.

Methods: We analyzed the clinical, immunologic, and genetic data of IEI patients from 22 countries in the Middle East and North Africa (MENA) region. The data was collected from national registries and diverse databases such as the Asian Pacific Society for Immunodeficiencies (APSID) registry, African Society for Immunodeficiencies (ASID) registry, Jeffrey Modell Foundation (JMF) registry, J Project centers, and International Consortium on Immune Deficiency (ICID) centers.

Results: We identified 17,120 patients with IEI, among which females represented 39.4%. Parental consanguinity was present in 60.5% of cases and 27.3% of the patients were from families with a confirmed previous family history of IEI. The median age of patients at the onset of disease was 36 months and the median delay in diagnosis was 41 months. The rate of registered IEI patients ranges between 0.02 and 7.58 per 100,000 population, and the lowest rates were in countries with the highest rates of disability-adjusted life years (DALY) and death rates for children. Predominantly antibody deficiencies were the most frequent IEI entities diagnosed in 41.2% of the cohort. Among 5871 patients genetically evaluated, the diagnostic yield was 83% with the majority (65.2%) having autosomal recessive defects. The mortality rate was the highest in patients with non-syndromic combined immunodeficiency (51.7%, median age: 3.5 years) and particularly in patients with mutations in specific genes associated with this phenotype (RFXANK, RAG1, and IL2RG).

Conclusions: This comprehensive registry highlights the importance of a detailed investigation of IEI patients in the MENA region. The high yield of genetic diagnosis of IEI in this region has important implications for prevention, prognosis, treatment, and resource allocation.

Keywords: Burden of disease; Epidemiology; Inborn errors of immunity; Molecular diagnosis; Primary immunodeficiency.

Conflict of interest statement

The authors declare no competing interests.


Figures


Similar articles

The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity.

Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, Reisli I, Tahiat A, Shendi HM, Elaziz DA, Belaid B, Al Dhaheri F, Haskologlu S, Dogu F, Ben-Mustapha I, Sobh A, Galal N, Meshaal S, Elhawary R, El-Marsafy A, Alroqi FJ, Al-Saud B, Al-Ahmad M, Al Farsi T, Al Sukaiti N, Al-Tamemi S, Mehawej C, Dbaibo G, ElGhazali G, Kilic SS, Genel F, Kiykim A, Musabak U, Artac H, Guner SN, Boukari R, Djidjik R, Kechout N, Cagdas D, El-Sayed ZA, Karakoc-Aydiner E, Alzyoud R, Barbouche MR, Adeli M, Wakim RH, Reda SM, Ikinciogullari A, Ozen A, Bousfiha A, Al-Mousa H, Rezaei N, Al-Herz W, Geha RS.J Allergy Clin Immunol Pract. 2023 Jan;11(1):158-180.e11. doi: 10.1016/j.jaip.2022.10.003. Epub 2022 Oct 17.PMID: 36265766 Review.

A Prospective Survey of Skin Manifestations in Children With Inborn Errors of Immunity From a National Registry Over 17 Years.

Al-Herz W, Zainal M, Nanda A.Front Immunol. 2021 Sep 30;12:751469. doi: 10.3389/fimmu.2021.751469. eCollection 2021.PMID: 34659256 Free PMC article.

Inborn Errors of Immunity in Algerian Children and Adults: A Single-Center Experience Over a Period of 13 Years (2008-2021).

Belaid B, Lamara Mahammed L, Drali O, Oussaid AM, Touri NS, Melzi S, Dehimi A, Berkani LM, Merah F, Larab Z, Allam I, Khemici O, Kirane SY, Boutaba M, Belbouab R, Bekkakcha H, Guedouar A, Chelali A, Baamara B, Noui D, Baaziz H, Rezak R, Azzouz SM, Aichaoui M, Moktefi A, Benhatchi RM, Oussalah M, Benaissa N, Laredj A, Bouchetara A, Adria A, Habireche B, Tounsi N, Dahmoun F, Touati R, Boucenna H, Bouferoua F, Sekfali L, Bouhafs N, Aboura R, Kherra S, Inouri Y, Dib S, Medouri N, Khelfaoui N, Redjedal A, Zelaci A, Yahiaoui S, Medjadj S, Touhami TK, Kadi A, Amireche F, Frada I, Houasnia S, Benarab K, Boubidi C, Ferhani Y, Benalioua H, Sokhal S, Benamar N, Aggoune S, Hadji K, Bellouti A, Rahmoune H, Boutrid N, Okka K, Ammour A, Saadoune H, Amroun M, Belhadj H, Ghanem A, Abbaz H, Boudrioua S, Zebiche B, Ayad A, Hamadache Z, Ouaras N, Achour N, Bouchair N, Boudiaf H, Bekkat-Berkani D, Maouche H, Bouzrar Z, Aissat L, Ibsaine O, Bioud B, Kedji L, Dahlouk D, Bensmina M, Radoui A, Bessahraoui M, Bensaadi N, Mekki A, Zeroual Z, Chan KW, Leung D, Tebaibia A, Ayoub S, Mekideche D, Gharnaout M, Casanova JL, Puel A, Lau YL, Cherif N, Ladj S, Smati L, Boukari R, Benhalla N, Djidjik R.Front Immunol. 2022 Apr 21;13:900091. doi: 10.3389/fimmu.2022.900091. eCollection 2022.PMID: 35529857 Free PMC article.

The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center.

Shendi HM, Al Kuwaiti AA, Al Dhaheri AD, Al-Hammadi S.Front Immunol. 2022 Jan 31;13:837243. doi: 10.3389/fimmu.2022.837243. eCollection 2022.PMID: 35173743 Free PMC article.

Genetics of Inborn Errors of Immunity in highly consanguineous Middle Eastern and North African populations.

Al-Mousa H, Barbouche MR.Semin Immunol. 2023 May;67:101763. doi: 10.1016/j.smim.2023.101763. Epub 2023 Apr 17.PMID: 37075586 Review.


Cited by

B cells and T cells abnormalities in patients with selective IgA deficiency.

Bagheri Y, Moeini Shad T, Namazi S, Tofighi Zavareh F, Azizi G, Salami F, Sadani S, Hosseini A, Saeidi M, Pashangzadeh S, Delavari S, Mirminachi B, Rezaei N, Abolhassani H, Aghamohammadi A, Yazdani R.Allergy Asthma Clin Immunol. 2023 Mar 20;19(1):23. doi: 10.1186/s13223-023-00775-6.PMID: 36941677 Free PMC article.

Demographic, clinical, immunological, and molecular features of iranian national cohort of patients with defect in DCLRE1C gene.

Ghadimi S, Jamee M, Abolhassani H, Parvaneh N, Rezaei N, Delavari S, Sadeghi-Shabestari M, Tabatabaei SR, Fahimzad A, Armin S, Chavoshzadeh Z, Sharafian S.Allergy Asthma Clin Immunol. 2023 Feb 21;19(1):13. doi: 10.1186/s13223-023-00768-5.PMID: 36810129 Free PMC article.

Clinical and Immunologic Characteristics of Non-Hematologic Cancers in Patients with Inborn Errors of Immunity.

Delavari S, Wang Y, Moeini Shad T, Pashangzadeh S, Nazari F, Salami F, Abolhassani H.Cancers (Basel). 2023 Jan 26;15(3):764. doi: 10.3390/cancers15030764.PMID: 36765721 Free PMC article.

Care of patients with inborn errors of immunity in thirty J Project countries between 2004 and 2021.

Abolhassani H, Avcin T, Bahceciler N, Balashov D, Bata Z, Bataneant M, Belevtsev M, Bernatowska E, Bidló J, Blazsó P, Boisson B, Bolkov M, Bondarenko A, Boyarchuk O, Bundschu A, Casanova JL, Chernishova L, Ciznar P, Csürke I, Erdős M, Farkas H, Fomina DS, Galal N, Goda V, Guner SN, Hauser P, Ilyina NI, Iremadze T, Iritsyan S, Ismaili-Jaha V, Jesenak M, Kelecic J, Keles S, Kindle G, Kondratenko IV, Kostyuchenko L, Kovzel E, Kriván G, Kuli-Lito G, Kumánovics G, Kurjane N, Latysheva EA, Latysheva TV, Lázár I, Markelj G, Markovic M, Maródi L, Mammadova V, Medvecz M, Miltner N, Mironska K, Modell F, Modell V, Mosdósi B, Mukhina AA, Murdjeva M, Műzes G, Nabieva U, Nasrullayeva G, Naumova E, Nagy K, Onozó B, Orozbekova B, Pac M, Pagava K, Pampura AN, Pasic S, Petrosyan M, Petrovic G, Pocek L, Prodeus AP, Reisli I, Ress K, Rezaei N, Rodina YA, Rumyantsev AG, Sciuca S, Sediva A, Serban M, Sharapova S, Shcherbina A, Sitkauskiene B, Snimshchikova I, Spahiu-Konjusha S, Szolnoky M, Szűcs G, Toplak N, Tóth B, Tsyvkina G, Tuzankina I, Vlasova E, Volokha A.Front Immunol. 2022 Dec 16;13:1032358. doi: 10.3389/fimmu.2022.1032358. eCollection 2022.PMID: 36605210 Free PMC article.

Diversity of malignancies in patients with different types of inborn errors of immunity.

Tavakol M, Delavari S, Salami F, Ansari S, Rasouli SE, Chavoshzadeh Z, Sherkat R, Ahanchian H, Aleyasin S, Esmaeilzadeh H, Moazzen N, Shafiei A, Abolnezhadian F, Iranparast S, Ebrahimi SS, Moeini Shad T, Pashangzadeh S, Nazari F, Rezaei A, Saeedi-Boroujeni A, Nabavi M, Arshi S, Fallahpour M, Bemanian MH, Sharafian S, Shokri S, Eshaghi S, Nazari S, Shamsian BS, Dargahi Mal-Amir M, Khazaei R, Ashkevari P, Khavandegar A, Haghi S, Esmaeili M, Abolhassani H, Rezaei N.Allergy Asthma Clin Immunol. 2022 Dec 12;18(1):106. doi: 10.1186/s13223-022-00747-2.PMID: 36510326 Free PMC article.


KMEL References


References

  1.  
    1. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol: In Practice. 2019;7(6):1763–70. - PubMed
  2.  
    1. Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S, et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020;16(7):717–732. doi: 10.1080/1744666X.2020.1801422. - DOI - PubMed
  3.  
    1. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x. - DOI - PMC - PubMed
  4.  
    1. Tangye SG, Al-Herz W, Bousfiha A, Cunningham-Rundles C, Franco JL, Holland SM, et al. The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS Committee. J Clin Immunol. 2021;41(3):666–679. doi: 10.1007/s10875-021-00980-1. - DOI - PMC - PubMed
  5.  
    1. Al-Herz W, Chou J, Delmonte OM, Massaad MJ, Bainter W, Castagnoli R, et al. Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. 2019;9:3146. doi: 10.3389/fimmu.2018.03146. - DOI - PMC - PubMed
  6.  
    1. Ziegler JB, Ballow M. Primary immunodeficiency: new approaches in genetic diagnosis, and constructing targeted therapies. J Allergy Clin Immunol Pract. 2019;7(3):839–841. doi: 10.1016/j.jaip.2018.12.019. - DOI - PubMed
  7.  
    1. Bazregari S, Azizi G, Tavakol M, Asgardoon MH, Kiaee F, Tavakolinia N, et al. Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency. Cent Eur J Immunol. 2017;42(4):336–341. doi: 10.5114/ceji.2017.72825. - DOI - PMC - PubMed
  8.  
    1. Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60(1):132–144. doi: 10.1007/s12026-014-8498-z. - DOI - PubMed
  9.  
    1. Quinn J, Modell V, Holle J, Truty R, Aradhya S, Johnson B, et al. Jeffrey’s insights: Jeffrey Modell Foundation’s global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment. Immunol Res. 2020;68(3):126–134. doi: 10.1007/s12026-020-09131-x. - DOI - PMC - PubMed
  10.  
    1. Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. doi: 10.1016/S0140-6736(20)30925-9. - DOI - PMC - PubMed
  11.  
    1. Collaborators GBDCC The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. Lancet Oncol. 2019;20(9):1211–1225. doi: 10.1016/S1470-2045(19)30339-0. - DOI - PMC - PubMed
  12.  
    1. Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health. 2009;6:17. doi: 10.1186/1742-4755-6-17. - DOI - PMC - PubMed
  13.  
    1. Abolhassani H, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, et al. National consensus on diagnosis and management guidelines for primary immunodeficiency. Immunol Genet J. 2019;2(1):1–21.
  14.  
    1. Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet. 2016;48(9):1071–1076. doi: 10.1038/ng.3592. - DOI - PMC - PubMed
  15.  
    1. Itan Y, Shang L, Boisson B, Ciancanelli MJ, Markle JG, Martinez-Barricarte R, et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat Methods. 2016;13(2):109–110. doi: 10.1038/nmeth.3739. - DOI - PMC - PubMed
  16.  
    1. Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet. 2017;100(2):267–280. doi: 10.1016/j.ajhg.2017.01.004. - DOI - PMC - PubMed
  17.  
    1. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. doi: 10.1038/gim.2015.30. - DOI - PMC - PubMed
  18.  
    1. Aghamohammadi A, Abolhassani H, Rezaei N, Yazdani R. Inborn errors of immunity: a practical guide. Academic Press. 2021.
  19.  
    1. Modell V, Orange JS, Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018;66(3):367–380. doi: 10.1007/s12026-018-8996-5. - DOI - PubMed
  20.  
    1. Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immuno. 2020;16(7):717–732. 10.1080/1744666X.2020.1801422 - PubMed
  21.  
    1. https://cci-reporting.uniklinik-freiburg.de/#/. (Access 28 Feb 2021).
  22.  
    1. https://lasidregistry.org/view/statistics. (Access 28 Feb 2021).
  23.  
    1. https://usidnet.org/registry-data/stats-registry-enrollment/. (Access 28 Feb 2021).
  24.  
    1. Abolhassani H, Chou J, Bainter W, Platt CD, Tavassoli M, Momen T, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–1458. doi: 10.1016/j.jaci.2017.06.049. - DOI - PubMed
  25.  
    1. Platt CD, Zaman F, Bainter W, Stafstrom K, Almutairi A, Reigle M, et al. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency. J Allergy Clin Immunol. 2021;147(2):723–726. doi: 10.1016/j.jaci.2020.08.022. - DOI - PMC - PubMed
  26.  
    1. Moens LN, Falk-Sorqvist E, Asplund AC, Bernatowska E, Smith CI, Nilsson M. Diagnostics of primary immunodeficiency diseases: a sequencing capture approach. PLoS ONE. 2014;9(12):e114901. doi: 10.1371/journal.pone.0114901. - DOI - PMC - PubMed
  27.  
    1. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, CobanAkdemir ZH, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139(1):232–245. doi: 10.1016/j.jaci.2016.05.042. - DOI - PMC - PubMed
  28.  
    1. Abolhassani H, Aghamohammadi A, Fang M, Rezaei N, Jiang C, Liu X, et al. Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency. Genet Med. 2019;21(1):243–251. doi: 10.1038/s41436-018-0012-x. - DOI - PubMed
  29.  
    1. Dezfouli M, Bergstrom S, Skattum L, Abolhassani H, Neiman M, Torabi-Rahvar M, et al. Newborn screening for presymptomatic diagnosis of complement and phagocyte deficiencies. Front Immunol. 2020;11:455. doi: 10.3389/fimmu.2020.00455. - DOI - PMC - PubMed